首页> 外国专利> 8--6--3--58--4-12378--- PROCESS FOR PREPARING 8-CYCLOPENTYL-6-ETHYL-3-SUBSTITUTED-58-DIHYDRO-4H-123A78-PENTAAZA-AS-INDACENES AND INTERMEDIATES USEFUL THEREIN

8--6--3--58--4-12378--- PROCESS FOR PREPARING 8-CYCLOPENTYL-6-ETHYL-3-SUBSTITUTED-58-DIHYDRO-4H-123A78-PENTAAZA-AS-INDACENES AND INTERMEDIATES USEFUL THEREIN

机译:8--6--3-[]-58--4-12378 ---制备8-环戊基-6-乙基-3- [取代的] -58-二氢-4H-123A78-PENTAAZA-AS-INDACENESS的方法并在其中进行中介

摘要

The present invention;(a) heating a solvent-free reaction mixture of γ-caprolactone and p-methoxybenzylamine to obtain an amide compound of formula (2) N-protected by p-methoxybenzyl;;(b) reducing the obtained amide compound of formula 2 to yield an amino alcohol compound of formula 3 N-protected by p-methoxybenzyl;;(c) acylating the obtained amino alcohol compound of formula (3) with ethyl oxalyl chloride to obtain an oxamic acid ethyl ester compound of formula (4) N-protected by p-methoxybenzyl;;(d) oxidizing the obtained oxamic acid ethyl ester compound of formula 4 to obtain an oxalamide ketone compound of formula 5, which is N-protected by p-methoxybenzyl;;(e) closing the obtained oxalamide ketone compound of formula (5) to obtain a pyridinone compound of formula (6) N-protected by p-methoxybenzyl;;(f) O-methylating the obtained pyridinone compound of formula (6) to obtain a 3-methoxy-pyridinone compound of formula (7) N-protected by p-methoxybenzyl;;(g) treating the obtained 3-methoxy-pyridinone compound of formula (7) with cyclopentylhydrazine to obtain a pyrazolopyridinone compound of formula (8) N-protected by p-methoxybenzyl;;(h) deprotecting the obtained pyrazolopyridinone compound of formula 8 by removing p-methoxybenzyl group therefrom to obtain a lactam compound of formula 9;;(i) esterifying the obtained lactam compound of formula (9) to obtain the corresponding imino ester (imidate) compound of formula (10); And;(j) treating the obtained imino ester (imide) compound of formula 10 with a carboxylic acid hydrazide compound of formula 11 to yield 8-cyclopentyl-6-ethyl-3- [substituted] Obtaining a -5,8-dihydro-4H-1,2,3a, 7,8-pentaza-asymmetric-indacene compound;8-cyclopentyl-6-ethyl-3- [substituted] -5,8-dihydro-4H-1,2,3a, 7,8-pentaza-asymmetric-indacene of formula 1 It relates to a process for the preparation of a compound and its pharmaceutically acceptable salts:;In the above formulas,;R 1 is hydrogen, alkyl, alkoxy, alkoxyalkyl, alkenyl, cycloalkyl, cycloalkylalkyl, saturated or unsaturated heterocyclic- (CH 2 ) n -group, or a group of formula;[Wherein,;All substituents are as described in detail herein].
机译:本发明;(a)加热γ-己内酯和对甲氧基苄胺的无溶剂反应混合物,得到由对甲氧基苄基N-保护的式(2)的酰胺化合物;(b)还原所得的酰胺化合物。式2得到由对甲氧基苄基N-保护的式3的氨基醇化合物;(c)用乙二酰氯氯酰化所得的式(3)的氨基醇化合物,得到式(4)的乙酰胺酸乙酯化合物)用对甲氧基苄基进行N-保护;(d)氧化所获得的式4的草酸乙酯化合物以获得式5的乙二酰胺酮化合物,用对甲氧基苄基进行N-保护;得到式(5)的草酰胺酮化合物,得到式(6)的吡啶酮化合物;用对甲氧基苄基N-保护;(f)O-甲基化得到的式(6)的吡啶酮化合物,得到3-甲氧基-由对甲氧基苄基N-保护的式(7)的吡啶酮化合物;;(g)处理所获得的3-me将式(7)的乙氧基-吡啶酮化合物与环戊基肼一起制得式(8)的吡唑并吡啶酮化合物,用对甲氧基苄基进行N-保护;(h)通过除去其中的对甲氧基苄基来脱保护所获得的式8的吡唑并吡啶酮化合物(9)将得到的式(9)的内酰胺化合物酯化,得到相应的式(10)的亚氨基酯(亚氨酸酯)化合物;并且;(j)用式11的羧酸酰肼化合物处理所得的式10的亚氨基酯(酰亚胺)化合物,得到8-环戊基-6-乙基-3- [取代的],得到-5,8-二氢- 4H-1,2,3a,7,8-五氮杂-不对称茚并茂化合物; 8-环戊基-6-乙基-3- [取代] -5,8-二氢-4H-1,2,3a,7,8式1的-五氮杂-不对称吲哚并苯的化合物及其药学上可接受的盐的制备方法:在上式中,R 1 是氢,烷基,烷氧基,烷氧基烷基,烯基,环烷基,环烷基烷基,饱和或不饱和杂环-(CH 2 n -基团或下式的基团; [其中,所有取代基如在这里详细]。

著录项

  • 公开/公告号KR100346619B1

    专利类型

  • 公开/公告日2002-07-26

    原文格式PDF

  • 申请/专利权人 화이자 프로덕츠 인코포레이티드;

    申请/专利号KR20000023025

  • 发明设计人 어반프랭크존;

    申请日2000-04-29

  • 分类号C07D471/14;C07D471/04;

  • 国家 KR

  • 入库时间 2022-08-22 00:29:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号